FOR TICHEP: INNOVATIVE TECHNOLOGIES FOR PERSONALYALYA (Q2310786)

From EU Knowledge Graph
Revision as of 14:33, 24 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in fr, and other parts: Adding French translations)
Jump to navigation Jump to search
Project Q2310786 in Italy
Language Label Description Also known as
English
FOR TICHEP: INNOVATIVE TECHNOLOGIES FOR PERSONALYALYA
Project Q2310786 in Italy

    Statements

    0 references
    64,292.8 Euro
    0 references
    128,585.53 Euro
    0 references
    50.0 percent
    0 references
    10 November 2017
    0 references
    30 June 2021
    0 references
    IRCCS CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO
    0 references
    0 references

    46°4'8.69"N, 12°35'26.12"E
    0 references
    IL PROGETTO MIRA A SVILUPPARE UN FRAME-WORK TECNOLOGICO INNOVATIVO PER LO SVILUPPO DI UNA CHEMIOTERAPIA PERSONALIZZATA E A RIDOTTA TOSSICITà, UTILIZZANDO IL CARCINOMA OVARICO COME MODELLO, MA CON POTENZIALITà DI ESTENSIONE AD ALTRI TIPI DI TUMORI. IN PARTICOLARE SI PREVEDE LO SVILUPPO DI UN SISTEMA TOTALMENTE AUTOMATIZZATO PER L¿ESECUZIONE DI TEST DI SENSIBILITà FARMACOLOGICA DA ESEGUIRE SU CELLULE DI CARCINOSI PERITONEALE PRELEVATE DA PAZIENTE AL FINE DI VALUTARE LA RISPOSTA INDIVIDUALE A (Italian)
    0 references
    THE PROJECT AIMS TO DEVELOP AN INNOVATIVE TECHNOLOGY FOR THE DEVELOPMENT OF PERSONALISED, REDUCED TOXIC CHEMOTHERAPY, USING OVARIAN AS A MODEL, BUT WITH THE POSSIBLE EXTENSION OF CANCER TO OTHER TYPES OF CANCER. IN PARTICULAR, IT IS EXPECTED THAT A FULLY AUTOMATED SYSTEM WILL BE DEVELOPED FOR UPTAKE OF PROFICIENCY TESTS TO BE PERFORMED ON PERITONEAL DAMS CELLS FROM PATIENTS IN ORDER TO ASSESS THE INDIVIDUAL RESPONSE TO (English)
    0 references
    LE PROJET VISE À DÉVELOPPER UN CADRE TECHNOLOGIQUE INNOVANT POUR LE DÉVELOPPEMENT D’UNE CHIMIOTHÉRAPIE PERSONNALISÉE ET PEU TOXIQUE, UTILISANT LE CANCER DE L’OVAIRE COMME MODÈLE, MAIS AVEC UN POTENTIEL D’EXTENSION À D’AUTRES TYPES DE TUMEURS. EN PARTICULIER, IL EST PRÉVU DE METTRE AU POINT UN SYSTÈME ENTIÈREMENT AUTOMATISÉ POUR LA RÉALISATION DE TESTS DE SENSIBILITÉ PHARMACOLOGIQUES À EFFECTUER SUR LES CELLULES PÉRITONÉALES DE LA CARCINOSE PRÉLEVÉES SUR LE PATIENT AFIN D’ÉVALUER LA RÉPONSE INDIVIDUELLE À (French)
    24 December 2021
    0 references

    Identifiers

    J36C18001230002
    0 references